These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 6997974)

  • 41. [Non-allergic eosinophilic rhinitis. From clinical diagnosis to pathogenic study].
    Moneret-Vautrin DA; Wayoff M; Hsieh V
    Ann Otolaryngol Chir Cervicofac; 1988; 105(7):553-7. PubMed ID: 3064674
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intranasal budesonide for the treatment of perennial rhinitis in Thai patients.
    Bunnag C; Dhorranintra B; Jareoncharsri P
    Asian Pac J Allergy Immunol; 1988 Dec; 6(2):116-20. PubMed ID: 3219158
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of nasal and blood eosinophilia in children suffering from perennial allergic rhinitis treated with beclomethasone dipropionate.
    Elkhalil M; Fiore L; Bellioni P; Cantani A; Corgiolu M; Businco L
    Allergol Immunopathol (Madr); 1983; 11(4):225-8. PubMed ID: 6650306
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effect of budesonide on the cytokine pattern in patients with perennial allergic rhinitis.
    Ciprandi G; Tosca MA; Cirillo I; Vizzaccaro A
    Ann Allergy Asthma Immunol; 2003 Nov; 91(5):467-71. PubMed ID: 14692430
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A parallel-group comparison of budesonide and beclomethasone dipropionate for the treatment of perennial allergic rhinitis in adults.
    al-Mohaimeid H
    J Int Med Res; 1993; 21(2):67-73. PubMed ID: 8243791
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of perennial secretory rhinitis.
    Bende M; Rundcrantz H
    ORL J Otorhinolaryngol Relat Spec; 1985; 47(6):303-6. PubMed ID: 2934671
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy and safety of intranasal budesonide in the treatment of perennial rhinitis in adults and children.
    Day JH; Andersson CB; Briscoe MP
    Ann Allergy; 1990 May; 64(5):445-50. PubMed ID: 2186673
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A double-blind comparison of nasal budesonide and oral astemizole for the treatment of perennial rhinitis.
    Bunnag C; Jareoncharsri P; Wong EC
    Allergy; 1992 Aug; 47(4 Pt 1):313-7. PubMed ID: 1443451
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of intra-nasal fenoterol solution on perennial allergic rhinitis.
    Yan K; Shaw J
    Eur J Respir Dis Suppl; 1983; 128 (Pt 2)():483-5. PubMed ID: 6352310
    [No Abstract]   [Full Text] [Related]  

  • 50. [Etiopathogenesis and clinical aspects of allergic and vasomotor rhinopathy].
    Mira E
    Recenti Prog Med; 1989; 80(7-8):377-82. PubMed ID: 2682853
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Assessment of the correlation of rhinometry with the symptoms and signs of allergic rhinitis in children.
    Welch MJ; Meltzer EO; Orgel HA; Kemp JP
    Ann Allergy; 1985 Oct; 55(4):577-9. PubMed ID: 3901833
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A clinical comparison of budesonide nasal aerosol, terfenadine and a combined therapy of budesonide and oxymetazoline in adult patients with perennial rhinitis.
    Lau SK; Wei WI; Van Hasselt CA; Sham CL; Woo J; Choa D; Engzell UC
    Asian Pac J Allergy Immunol; 1990 Dec; 8(2):109-15. PubMed ID: 1709020
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-term safety and efficacy of budesonide nasal aerosol in perennial rhinitis. A 12-month multicentre study.
    Lindqvist N; Balle VH; Karma P; Kärjä J; Lindström D; Mäkinen J; Pukander J; Ruoppi P; Suonpää J; Ostlund W
    Allergy; 1986 Apr; 41(3):179-86. PubMed ID: 3521382
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Double blind study and cross-over of the effect of nasal lavage with Prorhinel in chronic rhinitis].
    Polasek O; Haudenschild P
    Ther Umsch; 1987 Dec; 44(12):978-81. PubMed ID: 2450408
    [No Abstract]   [Full Text] [Related]  

  • 55. Budesonide - a new steroid for intranasal use. A double-blind clinical comparison between budesonide and placebo in patients with seasonal allergic rhinitis.
    Warland A; Møller P; Lindqvist N
    Allergy; 1981 Aug; 36(6):425-8. PubMed ID: 7032343
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Nasal provocation test in the diagnosis of vasomotor rhinitis].
    Polli G; Bacci P; De Luca O; Ciabatti PG; Fioretti C
    Acta Otorhinolaryngol Ital; 1983; 3(1):19-29. PubMed ID: 6880700
    [No Abstract]   [Full Text] [Related]  

  • 57. [Local therapy of rhinopathies with topically active glucocorticosteroid aerosols. Review].
    Albegger K
    Laryngol Rhinol Otol (Stuttg); 1985 Feb; 64(2):98-106. PubMed ID: 3982180
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A trial of intranasal Atrovent versus placebo in the treatment of vasomotor rhinitis.
    Knight A; Kazim F; Salvatori VA
    Ann Allergy; 1986 Nov; 57(5):348-54. PubMed ID: 2946252
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Budesonide in the treatment of nasal polyposis.
    Holopainen E; Grahne B; Malmberg H; Mäkinien J; Lindqvist N
    Eur J Respir Dis Suppl; 1982; 122():221-8. PubMed ID: 6958488
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical trial of a potent non-halogenated topical steroid, Budesonide.
    Agrup G; Björnberg A; Elmros T; Groth O; Hannuksela M; Lassus A; Salde L; Skogh M; Thomsen K
    Acta Derm Venereol; 1981; 61(2):180-2. PubMed ID: 6165205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.